Brigham And Women's Hospital
Clinical trials sponsored by Brigham And Women's Hospital, explained in plain language.
-
Experimental drug aims to halt rare heart disease
Disease control TerminatedThis study tested a drug called inotersen in 31 adults with TTR amyloid cardiomyopathy, a condition where abnormal protein builds up in the heart and causes progressive damage. The drug works by reducing the production of that protein in the liver. The goal was to see if it could…
Phase: PHASE2 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated May 16, 2026 23:48 UTC
-
Blood test may cut transfusions in severe postpartum bleeding
Disease control TerminatedThis study looked at whether a rapid blood test called ROTEM can help doctors manage transfusions better when women have severe bleeding after childbirth. The test detects early clotting problems, allowing targeted treatment. The goal was to reduce the amount of blood products ne…
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated May 16, 2026 23:47 UTC
-
New drug hope for rare skin blister condition
Disease control TerminatedThis study tested a daily pill called deucravacitinib for people with palmoplantar pustulosis, a condition that causes painful, pus-filled blisters on the palms and soles. Only 3 adults with moderate-to-severe symptoms took the drug for 24 weeks. The goal was to see if it improve…
Phase: PHASE4 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated May 16, 2026 23:37 UTC
-
New ablation combo tested for heart rhythm disorder
Disease control TerminatedThis study looked at two ways to treat paroxysmal atrial fibrillation (a type of irregular heartbeat). One method only isolates the pulmonary veins, while the other also isolates the back wall of the left atrium using a special energy called pulsed-field ablation. The goal was to…
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
UV light zaps mouth sores in transplant patients
Disease control TerminatedThis study tested whether shining a special narrow-band UVB light inside the mouth could help people with chronic graft-versus-host disease (cGVHD) who have painful mouth sores. Eleven participants, aged 4 and older, received the light treatment to see if it would improve their s…
Phase: PHASE2 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
Can a Melatonin-Like drug stop nighttime Acting-Out?
Symptom relief TerminatedThis early-stage study tested whether a daily 20 mg dose of tasimelteon, a drug that mimics melatonin, could reduce dream-enacting behaviors in people with REM behavior disorder. Twenty participants tracked their sleep and symptoms using daily logs and questionnaires. The study w…
Phase: EARLY_PHASE1 • Sponsor: Brigham and Women's Hospital • Aim: Symptom relief
Last updated May 13, 2026 15:58 UTC
-
MS fatigue drug study halted early
Symptom relief TerminatedThis study aimed to see if the drug ozanimod could help reduce fatigue in people with multiple sclerosis (MS). Researchers planned to track 26 adults with MS over three months using fatigue questionnaires and brain scans. The study was terminated early, so results are limited.
Sponsor: Brigham and Women's Hospital • Aim: Symptom relief
Last updated May 07, 2026 18:40 UTC
-
Perimenopause depression study halted after just 2 volunteers
Knowledge-focused TerminatedThis study aimed to understand how a natural brain chemical called allopregnanolone influences depression in women going through perimenopause. Researchers planned to measure changes in mood and thinking patterns. However, the study was stopped early and only enrolled 2 participa…
Phase: PHASE4 • Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated May 16, 2026 23:51 UTC
-
New imaging technique aims for safer lymph node biopsies
Knowledge-focused TerminatedThis study tested a method to guide surgical biopsies of lymph nodes in the abdomen using real-time imaging. The goal was to make the procedure safer and more accurate. Only 11 people took part before the study was stopped early.
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated May 15, 2026 11:55 UTC
-
Buddy system for arthritis patients fails to launch
Knowledge-focused TerminatedThis study aimed to see if pairing rheumatoid arthritis patients for one-on-one support could improve their health and understanding of the disease. About 65 adults with RA were to be matched with a buddy. The study was terminated early, so results are limited.
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated May 13, 2026 16:00 UTC